Putting Patients First
Learn more about how we are working to discover and develop innovative medicines that are more accessible and affordable to patients around the world.
We are advancing an innovative, high-value product portfolio for patients globally.
Passion with Purpose
We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.
Our Commitment to Patients
We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”
May 30, 2023
BRUKINSA® Approved in Canada for the Treatment of Chronic Lymphocytic LeukemiaRead more
May 25, 2023
BeiGene Presentations at the 2023 ASCO Annual Meeting Reinforce Promise Across Oncology PortfolioRead more
May 17, 2023
The Max Foundation, BeiGene, and the BeiGene Foundation Announce Collaboration to Advance Health Equity by Providing Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income CountriesRead more
May 4, 2023